Umbralisib Results from UNITY-NHL study published in the Journal of Clinical Oncology
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or…
–
Read More–
Dr. Xuan Ni Tan Awarded a State Government Fellowship
Dr. Xuan Ni Tan Researching the Benefits of Targeted Leukaemia…
–
Read More–
Pirtobrutinib results (formerly known as LOXO-305) published in The Lancet Journal
Pirtobrutinib in Relapsed or Refractory B-cell Malignancies (BRUIN): A Phase…
–
Read More–
Mosunetuzumab Shows Encouraging Results in Patients with High-Risk Follicular Lymphoma
Mosunetuzumab in Patients with High Risk Follicular Lymphoma (FL) Professor…
–
Read More–
Professor Cheah Discusses Early Results for LOXO-305 Trial
Professor Chan Cheah Discusses Early Results for Phase I LOXO-305…
–
Read More–